NewSquare Capital LLC Buys New Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

NewSquare Capital LLC purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 100 shares of the medical equipment provider’s stock, valued at approximately $44,000.

A number of other hedge funds have also recently added to or reduced their stakes in ISRG. Indiana Trust & Investment Management CO lifted its stake in shares of Intuitive Surgical by 5.3% in the second quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock worth $222,000 after buying an additional 25 shares in the last quarter. Hoxton Planning & Management LLC increased its position in Intuitive Surgical by 4.9% during the second quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock worth $238,000 after purchasing an additional 25 shares during the last quarter. First Affirmative Financial Network increased its position in Intuitive Surgical by 2.7% during the second quarter. First Affirmative Financial Network now owns 996 shares of the medical equipment provider’s stock worth $443,000 after purchasing an additional 26 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA increased its position in Intuitive Surgical by 0.3% during the fourth quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 8,899 shares of the medical equipment provider’s stock worth $3,002,000 after purchasing an additional 27 shares during the last quarter. Finally, Advance Capital Management Inc. increased its position in Intuitive Surgical by 3.8% during the first quarter. Advance Capital Management Inc. now owns 740 shares of the medical equipment provider’s stock worth $295,000 after purchasing an additional 27 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 584 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, May 28th. The shares were sold at an average price of $404.41, for a total value of $236,175.44. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,226,681.46. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director Amal M. Johnson sold 2,943 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total value of $1,304,631.90. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at $5,441,507.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 584 shares of the business’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $404.41, for a total transaction of $236,175.44. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,226,681.46. The disclosure for this sale can be found here. Insiders sold 15,309 shares of company stock worth $6,642,470 over the last 90 days. 0.90% of the stock is owned by insiders.

Intuitive Surgical Price Performance

Shares of ISRG stock traded up $3.70 during trading on Thursday, reaching $491.12. The company’s stock had a trading volume of 582,047 shares, compared to its average volume of 1,535,841. The company has a market capitalization of $174.20 billion, a price-to-earnings ratio of 88.43, a P/E/G ratio of 4.97 and a beta of 1.39. The stock’s 50-day moving average price is $446.95 and its 200 day moving average price is $409.81. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $491.83.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The firm had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. During the same quarter in the previous year, the business posted $1.18 earnings per share. The business’s quarterly revenue was up 14.5% compared to the same quarter last year. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms recently issued reports on ISRG. Truist Financial raised their price objective on shares of Intuitive Surgical from $450.00 to $515.00 and gave the stock a “buy” rating in a research report on Tuesday, July 16th. BTIG Research raised their price objective on shares of Intuitive Surgical from $451.00 to $459.00 and gave the stock a “buy” rating in a research report on Monday, July 15th. Stifel Nicolaus raised their price objective on shares of Intuitive Surgical from $430.00 to $475.00 and gave the stock a “buy” rating in a research report on Friday, July 19th. Piper Sandler raised their price objective on shares of Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a research report on Friday, July 19th. Finally, Robert W. Baird raised their price objective on shares of Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a research report on Friday, July 19th. Six research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $444.70.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.